Pictet Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Hold
3,686
﹤0.01% 928
2026
Q1
$1.77M Sell
3,686
-5,757
-61% -$2.95M ﹤0.01% 928
2025
Q4
$5.35M Sell
9,443
-20,270
-68% -$11.5M 0.01% 794
2025
Q3
$14.9M Sell
29,713
-11,202
-27% -$4.89M 0.01% 590
2025
Q2
$12.7M Sell
40,915
-5,634
-12% -$1.69M 0.01% 606
2025
Q1
$14.5M Sell
46,549
-7,035
-13% -$2.37M 0.02% 568
2024
Q4
$17.8M Sell
53,584
-3,401
-6% -$1.15M 0.02% 539
2024
Q3
$18.9M Sell
56,985
-2,760
-5% -$1.05M 0.02% 507
2024
Q2
$24.6M Sell
59,745
-122,664
-67% -$48.6M 0.03% 416
2024
Q1
$73.6M Sell
182,409
-14,044
-7% -$4.94M 0.08% 250
2023
Q4
$60.2M Buy
196,453
+8,544
+5% +$2.31M 0.07% 273
2023
Q3
$45.5M Buy
+187,909
New +$48.1M 0.06% 303

Other funds holding MEDP

Pictet Asset Management's MEDP Position: Q2 2026 in Review

Pictet Asset Management held its Medpace (MEDP) position steady in Q2 2026 at 3,686 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #928.

Pictet Asset Management first reported a position in MEDP in Q3 2023 and has held it in 12 quarters since. The position peaked at $73.6M in Q1 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Pictet Asset Management held 3,686 shares of Medpace worth $1.95M as of Q2 2026.
  • Pictet Asset Management left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #928 holding.
  • Pictet Asset Management first reported a position in Medpace in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Medpace position peaked at $73.6M in Q1 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.